scispace - formally typeset
M

Maryse Letiembre

Researcher at Saarland University

Publications -  9
Citations -  1378

Maryse Letiembre is an academic researcher from Saarland University. The author has contributed to research in topics: Neuroinflammation & Microglia. The author has an hindex of 9, co-authored 9 publications receiving 1243 citations.

Papers
More filters
Journal ArticleDOI

Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.

TL;DR: It is shown that a spontaneous loss-of-function mutation in the Tlr4 gene strongly inhibits microglial and monocytic activation by aggregated Alzheimer amyloid peptide resulting in a significantly lower release of the inflammatory products IL-6, TNFα and nitric oxide.
Journal ArticleDOI

LPS receptor (CD14): a receptor for phagocytosis of Alzheimer’s amyloid peptide

TL;DR: A direct role of CD14 in Abeta(42) phagocytosis is demonstrated, and a pronounced CD14 immunoreactivity on parenchymal microglia spatially correlated to characteristic Alzheimer's disease lesion sites in brain sections of Alzheimer’s disease patients but not inbrain sections of control subjects are detected.
Journal ArticleDOI

Screening of innate immune receptors in neurodegenerative diseases: a similar pattern.

TL;DR: A uniform pattern of innate immune response in animal models of neurodegenerative diseases clearly indicates that this response is part of a non-specific neuroinflammatory effector phase rather than a disease-specific event.
Journal ArticleDOI

Moderately elevated plant sterol levels are associated with reduced cardiovascular risk—The LASA study

TL;DR: Data suggest that plant sterols could have neutral or even protective effects on development of coronary heart disease, which have to be confirmed in interventional trials.
Journal ArticleDOI

Suppression of Microglial Inflammatory Activity by Myelin Phagocytosis: Role of p47-PHOX-Mediated Generation of Reactive Oxygen Species

TL;DR: It is concluded that phagocytosis of myelin suppresses microglial inflammatory activities via enhancement of p47-PHOX-mediated ROS generation, and suggests that intervention in ROS generation could represent a novel therapeutic strategy to reduce neuroinflammation in MS.